AI chatbot coaches teens through anxiety homework
NCT ID NCT07666672
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests BraveBot, a computer program that talks with young people (ages 12-22) through their phone or computer while they do exposure therapy homework for anxiety or OCD. BraveBot does not replace the therapist but offers real-time coaching and encouragement during assigned exercises. The goal is to see if using BraveBot helps youth understand their homework better, put in more effort, and feel more capable of handling anxiety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BraveBot (a GPT-powered audio-to-audio conversational assistant delivered via SMS)
What this could lead to
If it works, BraveBot could make exposure therapy homework more effective and easier for young people to stick with, potentially improving anxiety treatment outcomes.
What could go wrong
This is a small, early-stage study with only 50 participants, and it randomizes individual homework assignments rather than comparing groups, so results may not generalize widely. The tool is not a replacement for therapy and may not help everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Harvard University
Cambridge, Massachusetts, 02138, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
McLean Hospital
Belmont, Massachusetts, 02478, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••